Recruiting

Flexagon & Flexagon Plus

Sponsor:

GI Windows, Inc.

Code:

NCT07695558

Conditions

Small Bowel Anastomosis

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

Small Bowel Anastomosis

Study Details

Brief summary:

The objective of this study is to confirm the safety and effectiveness of the Flexagon \& Flexagon Plus OTOLoc systems when used to create respective side-to-side anastomosis in participants undergoing laparoscopic / endoscopic small bowel surgery.

Conditions

Small Bowel Anastomosis

Study ID

NCT07695558

Start date

Oct 27, 2026

Status verified date

Aug, 2026

Completion date

Jun, 2028

Anticipated

Primary completion date

Mar, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. >21 years of age, at the time of informed consent
2. Indicated for a side-to-side duodeno-ileal diversion, jejunum-jejunum or ileal-ileal anastomosis and no other concomitant surgical procedures (i.e. hiatal hernia repair, ventral hernia repair or gallbladder removal) planned in conjunction with SFM device placement
3. Willing and able to comply with the Registry procedures and provide written informed consent to participate in the post market study

Exclusion Criteria:

1. Participant does not provide informed consent to be enrolled and followed in the study
2. Participants for whom medical condition warrants use of device outside of indication for use
3. Breast-feeding, pregnant, or planning on becoming pregnant during the follow-up period.

Study Design

Enrollment

70 participants

Anticipated

Allocation

Non randomized

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

other: Duodeno-ileal diversion anastomosis

Small Bowel Anastomosis with Flexagon SFM Device

other: Jejunum-jejunum & ileal-ileal anastomosos

Small Bowel Anastomosis with Flexagon SFM Device with OTOLoc

Interventions

Small Bowel Anastomosis

Small Bowel Anastomosis

Primary outcome measure

  • Number of Participants with Successful Anastomosis Creation without the Need for Reoperation [ Time Frame: 30 Days ]

Central Contacts and Locations

Central contacts

Locations

Orlando Health Hospital

Recruiting

Orlando, Florida, United States, 32806

LSU Health

Recruiting

New Orleans, Louisiana, United States, 70112

More Information

Sponsor

GI Windows, Inc.

Last update posted

Nov 16, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by GI Windows, Inc. on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.